Recent Trials & New Therapies for Treating ED
August 25, 2026
Erectile dysfunction is a form of sexual impotence where there is inability to achieve or maintain an adequate penile erection for satisfactory sexual intercourse. ED is a common condition, and its prevalence rises with age. While there is no set time frame for diagnosing experiencing erectile issues, some experts recommend that normally the condition should persist for six months before a thorough diagnosis is needed.
ED is also a very important but underappreciated cardiovascular risk factor that can signal a wide range of underlying diseases. It can be brought on by any disease process that affects the tunica albuginea, hormone levels, smooth muscle tissue, body endothelium, or penile arteries. Hyperlipidemia, hypertension, diabetes mellitus, cardiovascular illnesses, and other conditions are directly linked. Endothelial dysfunction also appears to be a common mechanism in men with ED.
While organic diseases account for the great majority of ED patients, some patients (especially younger men) may have a primary psychological cause. Even when the underlying cause is organic, psychological factors from marital and relational issues, cultural expectations, anxiety, shame, loss of self-esteem, and depression are often involved. Nonetheless, PDE5 inhibitors remain the standard first-line treatment, while newer approaches aim to repair underlying tissue and blood flow rather than just manage symptoms.
What are the newest treatments for erectile dysfunction?
The newest treatments for erectile dysfunction focus on medications and therapies that are more effective, work rapidly, and have fewer side effects than currently available options. A number of pharmaceutical companies are researching new ED treatments, and many new options may be just around the corner. These include PRP injections, shockwave therapy, stem cell therapy, GLP-1 receptor agonists, melanocortin activators, and gene therapy.
Can platelet-rich plasma injections heal erectile dysfunction?
Results are mixed. Some studies show meaningful improvements in erectile function, while other strict clinical trials show no difference compared to a placebo. Because the plasma comes from your own body, serious risks or allergic reactions are rare, though temporary bruising, swelling, or minor pain at the injection site can occur. Here is how PRP treatment works:
- A medical provider takes a small sample of your blood.
- The blood goes into a machine called a centrifuge to separate the platelets and growth factors.
- The concentrated plasma is injected into the spongy tissue of the penis.
Experts note that more large-scale research is needed before PRP becomes a standard guideline recommendation. Also known as the P-Shot, platelet-rich plasma injections use concentrated growth factors from your own blood to try to repair tissue and improve blood flow. Platelets are cell fragments in your blood that can help heal wounds and grow new blood vessels.
Is shockwave therapy a non-invasive treatment option for ED?
Yes. Shockwave therapy is a non-invasive treatment that uses low-energy sound waves to stimulate the growth of new blood vessels and improve blood flow to the penis. Some men in the United States seeking relief for ED are choosing this option over prescriptions for Viagra, though the treatment remains controversial. Since high-energy sound waves had been used for decades to shatter kidney stones, doctors ran a trial of low-intensity sound waves in 20 middle-aged men with ED. Six months after treatment, half of the men improved enough to engage in penetrative sex without the aid of Viagra-type drugs. Since one of the underlying functional causes of ED is poor arterial blood flow, it appears that the shockwaves stimulate the production of new blood vessels, which in turn improves erectile function. This makes shockwave therapy best suited for men whose ED is caused by vascular problems rather than medications, anxiety, or other nonvascular factors.
Why has stem cell therapy been inconsistent for ED in humans?
Promising outcomes have been observed in multiple animal models, but success in humans has so far been inconsistent and largely dependent on the stem cell donor. Stem cell therapy for ED uses stem cells, either from you or a donor, to renew and repair damaged endothelial cells and penile tissue. Rather than masking symptoms like oral medications do, this emerging experimental treatment aims to restore natural erections by repairing damaged blood vessels and nerves. Doctors inject stem cells directly into the penile tissue, or the cells may be received through IV infusion. The cells differentiate into neuronal, smooth muscle, and endothelial cells to restore tissue loss in ED-related penile structures. It is often studied for men who do not respond to standard pills like Viagra or Cialis.
Is gene therapy currently FDA-approved for treating erectile dysfunction?
No, but gene therapy for ED is an experimental approach. In animal studies and small early-phase human safety trials, it has shown that gene transfer is feasible and generally well-tolerated. However, long-term safety and effectiveness must still be established through large-scale clinical trials, and gene therapy may take a long time to gain regulatory approval and public acceptance. The penis is a convenient tissue target for gene therapy because of its external location and accessibility, the ubiquity of endothelial-lined spaces, and low level of blood flow, especially in the flaccid state. Treatments focus on fixing cellular pathways that control blood flow and smooth muscle relaxation. Scientists use viral or non-viral vectors to transfer healthy genetic material directly into the smooth muscle of the penis. The method aims to help hard-to-treat patients, such as those with diabetes or nerve damage from prostate surgery, who do not respond to standard PDE5 pills.
Can the latest GLP-1 receptor agonists reduce ED risk factors?
The good news is that weight-related ED is likely reversible. Experts say losing just 10% of your body weight can significantly improve erectile function. Because the arteries supplying the penis are very small, atherosclerosis often shows up in the bedroom first. Recent studies suggest that up to 79% of men with ED are overweight, and being overweight or obese can increase the risk of developing ED by up to 90%. Excess weight also compromises vascular health: fat deposits can cause atherosclerosis, where plaque builds up in penile arteries and blood vessels struggle to dilate properly. GLP-1 receptor agonists may help treat weight-related ED by supporting weight loss and restoring endothelial function. When a man carries excess weight, particularly abdominal belly fat, changes to body mass index (BMI) are a key indicator that losing even modest amounts of weight can improve sexual performance.
Frequently Asked Questions – Fixing Erectile Dysfunction
Q: Which treatments are proven vs. still experimental?
A: PDE5 inhibitors like Viagra and Cialis are proven, FDA-approved first-line treatments. PRP injections, shockwave therapy, stem cell therapy, melanocortin activators, and gene therapy are still considered experimental and require larger clinical trials before becoming standard options.
Q: Can losing weight improve erectile dysfunction?
A: Yes. Because obesity compromises vascular health and contributes to atherosclerosis in penile arteries, losing weight can help. Experts say losing just 10% of your body weight can significantly improve erectile function, and GLP-1 receptor agonists may support this weight loss.
Q: What causes erectile dysfunction?
A: ED can be caused by physical (organic) factors such as hypertension, diabetes, hyperlipidemia, cardiovascular disease, and endothelial dysfunction, as well as psychological factors like anxiety, depression, and relationship issues. In many men, both physical and psychological factors contribute.
Q: How should I choose between ED treatments?
A: PDE5 inhibitor pills are best suited for most men as a first step, while shockwave and PRP therapies may appeal to those with vascular-related ED seeking non-drug options. Stem cell and gene therapy are best considered by men who do not respond to standard pills, though these remain experimental. Always consult a healthcare provider to match treatment to your underlying cause and health history.
________________________
While organic diseases account for the great majority of ED patients, some patients including younger men may have ED associated with a psychological issue. Even though the underlying cause may be organic, it may also be linked to marital or relational problems, faulty expectations, lustful anxiety, shame, loss of self-esteem, depression, as well as crucial physical factors too. Treatments for erectile dysfunction today focus on providing options that are more effective, work rapidly, and have few (if any) side effects. ED medications like PDE5 inhibitors (the little blue pill) actually block the PDE5 enzyme that normally breaks down the molecules responsible for achieving an erection to allow it become flaccid. Because these medications only protect the messenger rather than create it from scratch, they do not cause spontaneous erections. Natural sexual stimulation is still necessary to jumpstart the nitric oxide release. By stopping this enzyme, blood vessels relax and blood flow to the penis increases. Although PDE5 meds work well for some men, others prefer options that work for longer periods after each treatment. For the most up-to-date personal advice regarding your options, schedule a consultation with Dr. Eye and his team at GAINSWave Jacksonville today by calling (904) 500-5500.
